CD19 and cavernous hemangioma: In general, the identified MSCs in cavernous hemangioma meet the above criteria, as they highly expressed NT5E and THY1, however, lowly or very lowly expressed ENG, PTPRC, CD34, CD14, ITGAM, CD79A, and CD19, compared with other cells.